ArticleCancer research2017

Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ.

Ruth J Davis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.